| Date Filed | Type | Description |
| 05/10/2023 |
4
| GRANGE DAVID L (Director) has filed a Form 4 on Tonix Pharmaceuticals Holding Corp.|
Txns:
| Granted 60,000 options
@ $0.509, valued at
$30.5k
|
|
| 05/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/06/2020 |
4
| GRANGE DAVID L (Director) has filed a Form 4 on Tonix Pharmaceuticals Holding Corp.|
Txns:
| Granted 75,000 options
@ $0 |
|
| 05/08/2019 |
4
| GRANGE DAVID L (Director) has filed a Form 4 on Tonix Pharmaceuticals Holding Corp.|
Txns:
| Granted 30,000 options
@ $2.05, valued at
$61.5k
|
|
| 06/13/2018 |
4
| GRANGE DAVID L (Director) has filed a Form 4 on Tonix Pharmaceuticals Holding Corp.|
Txns:
| Granted 20,000 options
@ $4.25, valued at
$85k
|
|
| 02/21/2018 |
3
| GRANGE DAVID L (Director) has filed a Form 3 on Tonix Pharmaceuticals Holding Corp. |
| 02/15/2018 |
4
| GRANGE DAVID L (Director) has filed a Form 4 on Tonix Pharmaceuticals Holding Corp.|
Txns:
| Granted 7,000 options
@ $3.4, valued at
$23.8k
|
|
| 03/01/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/04/2010 |
4
| GRANGE DAVID L (CEO) has filed a Form 4 on PHARMACEUTICAL PRODUCT DEVELOPMENT INC|
Txns:
| Sold 373 shares
@ $26, valued at
$9.7k
Sold 51,380 shares
@ $25.71, valued at
$1.3M
Exercised 373 options to buy
@ $21.98, valued at
$8.2k
Exercised 51,380 options to buy
@ $21.98, valued at
$1.1M
|
|
| 06/18/2010 |
4
| GRANGE DAVID L (CEO) has filed a Form 4 on PHARMACEUTICAL PRODUCT DEVELOPMENT INC|
Txns:
| Granted 50,000 options to buy
@ $26.64, valued at
$1.3M
|
|
| 03/01/2010 |
4
| GRANGE DAVID L (CEO) has filed a Form 4 on PHARMACEUTICAL PRODUCT DEVELOPMENT INC|
Txns:
| Granted 100,000 options to buy
@ $21.17, valued at
$2.1M
|
|
| 07/02/2009 |
4
| Form 4 -- Statement of changes in beneficial ownership of securities |
| 01/05/2009 |
4
| GRANGE DAVID L (Director) has filed a Form 4 on PHARMACEUTICAL PRODUCT DEVELOPMENT INC |